Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
What's inside Mexico's Popocatépetl? Scientists obtain first 3D images of the whole volcano - 2Vote in favor of the juice that you love for its medical advantages!
- 3Innospace's rocket crashes in first commercial launch in Brazil; shares tumble
- 4Go on A Careful spending plan: Modest Objections for Your List of must-dos
- 5Top 15 Online Entertainment Stages for Individual Marking
- ‘We are the alternative’: Anti-Hamas Gaza militia tells BBC group is receiving international support
- Illumina unveils dataset to speed up AI-powered drug discovery
- Must-Have Wellness Gear: What to Purchase for Successful Exercises
- 5 High Limit Outer Hard Drives For Information Stockpiling
- 2024 Moving Styles for Kitchen Redesigns
- 10 Activities to Lift Your Consume and Bust Your Stomach
- Malaysian broadcaster rejects altered graphic about electricity rate hike
- Senior's Manual for Obtaining a Hyundai Ioniq EV: Tips
- EU delegation urges China to tighten export controls
